TEVA Stock Teva Pharmaceutical Industries (TEVA, $26.89) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 28, 2025

GET DAILY SIGNALS

Get AI intraday signals

TEVA - Teva Pharmaceutical Industries Limited

MACD signal

View

Odds of UP Trend

Price: $26.89

Daily change: +$0.57 (+2.17%)

Daily volume: 9M

Capitalization: $30B

Industry: Pharmaceuticals: Generic

This is a Bullish indicator signaling TEVA's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 42 similar cases where TEVA's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

TEVA's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TEVA turned positive on November 28, 2025. Looking at past instances where TEVA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on TEVA as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TEVA advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 231 cases where TEVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TEVA broke above its upper Bollinger Band on November 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TEVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.228) is normal, around the industry mean (17.312). P/E Ratio (43.803) is within average values for comparable stocks, (72.847). Projected Growth (PEG Ratio) (0.811) is also within normal values, averaging (1.956). TEVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.837) is also within normal values, averaging (55.504).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.